Know and Own Your Movement-related Metrics Via Wearable Devices
NCT ID: NCT05490641
Last Updated: 2025-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2023-03-29
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
NCT06840028
Wearable Exercise Trackers in Cancer Rehabilitation
NCT03042884
Implementing Personalized Exercise Prescriptions Through Mobile Health in the Elderly Cancer Survivors
NCT05069519
Self-monitoring Physical Activity With a SMARTphone Application in Cancer Patients: a Feasibility Study (SMART)
NCT02391454
Survivor mHealth: Wearable Devices in Cancer Survivors
NCT05417438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The overall goals for this study are: (1) to test the preliminary effect of a remotely delivered physical activity intervention that incorporates personalized biological-based feedback on daily physical activity levels, and (2) to explore the association between daily glucose patterns and cancer-related insulin pathway and inflammatory biomarkers in cancer survivors who are at high risk for type 2 diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biofeedback Group
Glucose-based biofeedback
Participants will wear a Fitbit activity tracker and receive personalized text messages over a 12-week period. During the first 4 weeks of the study period, participants will also wear a continuous glucose monitor to check their glucose levels in real-time and receive text messages based on their activity and glucose data.
Standard Care Group
Standard feedback
Participants will wear a Fitbit activity tracker and receive non-personalized text messages over a 12-week period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucose-based biofeedback
Participants will wear a Fitbit activity tracker and receive personalized text messages over a 12-week period. During the first 4 weeks of the study period, participants will also wear a continuous glucose monitor to check their glucose levels in real-time and receive text messages based on their activity and glucose data.
Standard feedback
Participants will wear a Fitbit activity tracker and receive non-personalized text messages over a 12-week period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have had a diagnosis of cancer
* have completed curative-intended treatment for at least 3 months (except hormone therapy or long-term maintenance chemotherapy)
* be at high-risk for type 2 diabetes based on the American Diabetes Association Type 2 Diabetes Risk Test
* currently insufficiently active
* capable of participating in moderate-vigorous intensity unsupervised exercise
* have no current diagnosis or history of type 1 or 2 diabetes
* able to speak, read, and write in English
* have a smartphone with daily internet access
Exclusion Criteria
* current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin
* currently pregnant
* on dialysis
* have self-reported health issues that limit physical activity
* work overnight shifts
* unwilling to use the study devices
* current participation in other exercise or weight loss-related program or intervention
* currently on a low-carb diet
* current use of other implanted medical devices such as pacemakers
* do not have a smartphone that is compatible with the Fitbit and the LibreLink apps
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Institute for Cancer Research
OTHER
The University of Texas at Arlington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yue Liao
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yue Liao, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Texas at Arlington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas at Arlington
Arlington, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Liao Y, Schembre SM, Brannon GE, Pan Z, Wang J, Ali S, Beg MS, Basen-Engquist KM. Using wearable biological sensors to provide personalized feedback to motivate behavioral changes: Study protocol for a randomized controlled physical activity intervention in cancer survivors (Project KNOWN). PLoS One. 2022 Sep 13;17(9):e0274492. doi: 10.1371/journal.pone.0274492. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0177
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.